This Policy Forum reviews the literature on the impact of AIDS on selected MDGs, and explores the links between fighting AIDS and improving other development outcomes. It also considers the implications for developing country and donor investment strategies, arguing that expanded investment in HIV prevention—especially in new prevention tools including AIDS vaccines—is essential for attaining and upholding the MDGs.

Adherence to highly active antiretroviral therapy (HAART) medication is the greatest patient-enabled predictor of treatment success and mortality for those who have access to drugs. We systematically reviewed the literature to determine patient-reported barriers and facilitators to adhering to antiretroviral therapy.